cropper
update
National Cannabis Newswire
update
  • Home
  • Categories
    • news
    • trends
    • insights
    • industry
    • legalization
    • health
    • culture
    • advocacy
    • Brands
    • New Mexico Dispensaries
    • Arizona Dispensaries
March 11.2026
3 Minutes Read

What's Going On With Cannabis? Colorado Considers Tax Increase Amid Sales Drop

Colorado considers cannabis tax hike amid declining sales

Understanding the Proposed Cannabis Tax Hike in Colorado

Colorado is currently considering a cannabis tax hike as part of a proposal aimed at generating revenue for mental health services. The suggestion, which could see state retail marijuana sales and excise taxes rise by less than half a percentage point, may seem modest but poses significant implications for an already struggling cannabis market. With cannabis taxes possibly increasing to around 27% in areas like Denver, these changes come in the wake of declining sales in the state’s legal marijuana market.

The Current Landscape of Colorado's Cannabis Market

In recent years, Colorado’s cannabis sales have seen a steep decline. After peaking during the pandemic, sales fell for the fourth consecutive year, highlighting growing challenges in the industry. According to state data, tax revenue from cannabis sales dropped drastically, falling from a peak of $424 million in the 2020-21 budget year to an anticipated $248 million for 2023-24. Such declines aren’t solely attributed to the pandemic's aftermath but also indicate broader market shifts, including increasing competition from the illicit cannabis market and the rise of intoxicating hemp products.

A Comparison of Trends Across States

Colorado isn't the only state feeling the burn from cannabis tax policies; other states like California and Michigan have also observed downturns in sales directly linked to increased tax burdens. For instance, California reports significant dips in sales as taxes spiked, leading consumers to reconsider their purchasing decisions, often favoring cheaper illicit options. Michigan's wholesale tax increase resulted in a considerable crash in sales, a lesson seen echoed in Colorado's tax debates. This presents a compelling cautionary tale for Colorado legislators as they weigh the potential impacts of further tax increases.

Impact of Rising Taxes on Consumer Behavior

Industry advocates in Colorado argue that raising taxes amid declining sales risks exacerbating the industry's challenges. Increased taxes may not generate the anticipated revenue if they push consumers towards the black market, impacting overall tax collections. The feedback from previous tax increases in other states suggests a trend: high prices combined with high taxes often drive consumers to seek alternatives outside of regulated dispensaries, which ultimately stifles market growth and tax revenue.

The Future of Cannabis Revenue in Colorado

The question arises: What does the future hold for Colorado's cannabis revenue? The state faces a projected budget deficit of nearly $1 billion, prompting lawmakers to explore viable financial solutions, including cannabis taxes. However, increasing taxes in a declining market is a delicate balancing act that could lead to further financial pitfalls. A more strategic approach may involve finding ways to support the cannabis industry through reduced taxes or innovative programs designed to stimulate legal market sales rather than imposing additional financial pressures.

Your Role in Shaping Cannabis Regulation

As stakeholders in the cannabis community, staying informed and active in discussions surrounding tax policies is crucial. Engaging with local legislators, participating in advocacy campaigns, and understanding the implications of such tax proposals not only benefit your business but also contribute to the industry's broader health. Now more than ever, it's essential to unite and make your voices heard to ensure that any changes in regulation are beneficial for everyone involved in the cannabis market.

news

24 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts

Win a Trip to Tulum by Visiting Lume's Newest Dispensary!

Update Experience Cannabis Culture at Lume's New Buffalo LocationAs the legal cannabis market continues to expand in Michigan, Lume Cannabis Co. stands out with its latest dispensary opening in New Buffalo. To celebrate, they are giving away a principal prize—a luxury trip for two to the beautiful beaches of Tulum, Mexico. This initiative not only aims to attract cannabis enthusiasts but also highlights the store's modern, customer-focused philosophy that resonates deeply with visitors. The giveaway, titled “From a Lume to a Tulum Weekend Getaway,” runs from May 2 to May 3 and is likely to draw both locals and travelers from nearby cities.Promotion That Captivates and ConnectsUnlike the typical grand openings that might offer discounts or free merchandise, Lume is making waves with a trip to Tulum—a destination that combines relaxation and adventure. With customers excited about the chance for a tropical escape, this marketing approach aligns directly with contemporary cannabis culture, which emphasizes lifestyle and experience alongside product consumption. It’s not just about visiting a dispensary; it's about creating memorable moments linked to cannabis use.Quality and Service That Define the BrandLume focuses on providing quality products and top-tier service. Their staff, fondly referred to as Luminaries, are well-informed and passionate about cannabis, ensuring customers have an easy and enjoyable shopping experience. The dispensary employs a fast-lane order pickup system, which reduces wait times significantly, a crucial factor for busy weekends when foot traffic is high. Previous customers have noted Lume's high ratings and consistency, which speaks volumes in an industry ripe with options. Lume's model guarantees quality—cultivating and selling its cannabis while also partnering with other reputable brands, thus ensuring diverse product offerings.A Welcoming Space for All CustomersThe New Buffalo dispensary is especially appealing to tourists and residents alike, targeting traffic from Indiana and the greater Chicago area. With notable strain names like Jenny Kush and Chem de la Chem, there’s something for every preference—from regular consumers to novices exploring cannabis culture for the first time. New customers also enjoy a free product on their first purchase, enhancing engagement and fostering a return visit through loyalty programs that offer progressive discounts.The Power of Cannabis Loyalty ProgramsLume's approach goes beyond just a great product; its Cannabis Club loyalty program creates a solid incentive for frequent shoppers. After the first purchase, loyal members receive a 40% off coupon and an increased 50% off on their second visit, alongside access to exclusive deals and products. This model nurtures a community of returning customers who appreciate value and quality in their cannabis experience, a crucial aspect as competition increases in the sector.The dynamic marketing and genuine customer service that Lume has adopted might set a new benchmark for how cannabis dispensaries engage with their communities. With their large focus on quality, education, and customer experience, Lume is poised not only to attract but also to retain a diverse customer base. Amidst a building cannabis culture, they mark a forward stride toward integrated experiences that highlight the multifaceted nature of cannabis.If you’re intrigued by Lume's offerings and interested in becoming part of their growing community, make sure to visit the new dispensary during the grand opening for a chance at the Tulum getaway!

Cannabis Rescheduling: A Game-Changer for Industry Investment and Justice

Update The Shift in Cannabis Policy: A Historic MoveOn April 23, 2026, a significant paradigm shift took place in cannabis legislation as the federal government officially reclassified medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. This change, reported initially by the Associated Press, was executed under the Trump administration after months of increasing pressure within the Department of Justice. This represents the most monumental shift in U.S. cannabis policy in over five decades, indicating the recognition of cannabis's medical utility for the first time since 1970.According to Darren Lampert, CEO of GrowGeneration Corp., this decision is a crucial turning point for the industry, ushering in a much-needed update of federal policy. "Today’s rescheduling of cannabis marks a historic turning point for the industry and a long-overdue modernization of federal policy," Lampert stated, underscoring how this acknowledgment of medical use supports the expansion of scientific research and removes barriers to patient access. Moreover, the rescheduling is likely to have immediate ripple effects across the broader cannabis economy.Long-Term Implications: Economic Growth and InvestmentWith this new classification, cannabis is no longer placed in the same prohibitive category as heroin under federal law. Instead, it is recognized for its therapeutic value, paving the way for increased funding and investment into the cannabis sector. Lampert emphasized that such regulatory clarity will propel growth and efficiency across the market, enabling companies within the industry to attract more substantial investments and create more jobs.Interestingly, this change comes at a time when nearly 40 states have already established medical cannabis programs, providing millions of patients with access to marijuana products. Therefore, the shift in legislation could spur further development in those states, inspiring neighboring regions to consider similar avenues of legalization.Acknowledging the Past: Justice for Those IncarceratedHowever, this shift also raises pressing questions concerning social justice. As cannabis gains recognition for its medical value, there is an ethical duty to reflect on those who suffered due to the previous legal classifications. Thousands remain incarcerated or carry criminal records from actions now partially viewed as medically acceptable. Activists for drug policy reform argue that these individuals deserve clemency given the new context. Moreover, this change could become a catalyst for broader discussions about justice in the realm of drug enforcement.Geoff Whaling, Chairman of the National Hemp Association, noted that while this federal acknowledgment does not directly impact hemp—previously removed from the Controlled Substances Act under the Agriculture Improvement Act of 2018—it is another significant step in normalizing the broader cannabis category. This normalization is vital to modify the public perception of cannabis while furthering research into its potential benefits.Future Trends in Cannabis LegislationThe advancement in cannabis policy signals the start of a new chapter within the industry. As more states see the economic and health benefits associated with this lucrative market, the potential for legalization at the federal level may no longer feel like a distant dream.As the cannabis community celebrates this momentous occasion, it must also stay aware of the work that lies ahead—pushing for justice, further research, and continuous effort to streamline regulations surrounding cannabis usage. This reality is at our doorstep, and what happens next will impact not only the industry but, more importantly, the lives of those who rely on its therapeutic potential.

What Does Marijuana Rescheduling Mean for Cannabis Companies Today?

Update Understanding the Impact of Marijuana Rescheduling The much-anticipated potential rescheduling of marijuana from Schedule I to Schedule III of the Controlled Substances Act is not just a bureaucratic change—it represents a seismic shift in the cannabis landscape. This adjustment, as advocated by the U.S. Department of Health and Human Services (HHS), is based on evolving scientific and medical insights that recognize marijuana's therapeutic applications. If this rescheduling occurs, it is expected to have significant ripple effects through the cannabis industry, shaping everything from business operations to consumer access. Why Rescheduling Matters Currently classified as a Schedule I drug—alongside substances deemed to have no acceptable medical use—marijuana is burdened by restrictions that continue to stifle research and complicate banking options for cannabis businesses. Moving it to Schedule III could enable more comprehensive research endeavors and potentially open doors for companies to assert tax deductions that are mostly unavailable to Schedule I entities due to Section 280E of the Internal Revenue Code. The prospect of these benefits has generated excitement across the industry, but some experts caution against expectations of immediate relief in all areas; the transition will likely be complex and gradual. How Cannabis Companies Are Preparing Industry leaders are optimistic, viewing rescheduling as an opportunity to innovate and expand. Kim Rivers, CEO of Trulieve, noted that the change signals an acknowledgment of marijuana's medical use, creating a pathway for more integrated and regulated medical applications. Similarly, Irwin Simon from Tilray Brands mentioned that this transition could accelerate clinical research and elevate product standards, transforming cannabis into a legitimate component of modern healthcare. Such advancements would not only enhance choice for consumers but also professionalize the industry further. Financial Implications for the Cannabis Sector One of the significant implications of rescheduling could be the easing of financial constraints that cannabis companies face. As noted in recent discussions, banks may become more open to providing financial services to marijuana businesses if the rescheduling occurs. This could translate to improved access to capital, vital for companies aiming to grow and innovate. Additionally, a realignment in regulatory expectations might encourage a more robust investment climate, attracting new players to the sector. The Road Ahead: Challenges and Opportunities Despite this wave of optimism, challenges remain in the wake of potential rescheduling. Critics worry about the clarity of regulations and the risk of oversimplifying how cannabis products can be categorized. Companies have to navigate complex state laws alongside federal changes, creating a patchwork of operations that could complicate enforcement and policy-making. Furthermore, industry experts reiterate that rescheduling does not automatically alter the overall legality of marijuana nor resolve banking complexities overnight. The forthcoming hearing by the DEA on this matter is crucial for capturing detailed community sentiments and addressing specific concerns surrounding implementation. Looking at the Long-Term Impact The future of cannabis hinges not only on this momentous rescheduling but on ongoing innovations, discussions around regulatory frameworks, and the establishment of a solidified market identity. As jurisdictions and consumers adapt to these evolving landscapes, maintaining open channels of communication and collaboration between industry stakeholders, government entities, and community members will be essential to ensure the benefits of rescheduling are realized across the board. This prospective shift in marijuana's legal classification carries potential benefits and challenges. Those who vigilantly monitor these developments will better understand "what is going on with cannabis?" and how to navigate the inevitable changes ahead in the cannabis industry landscape.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*